Renin-angiotensin-aldosterone system blockers after KDIGO stage 3 acute kidney injury: use and impact on 2-year mortality in the AKIKI trial

Overview of attention for article published in Critical Care, April 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (77th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 15 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 15 X posts from 15 X users, with an upper bound of 54,863 followers.

Letter by @StephaneG05 and Didier Dreyfuss team Renin-angiotensin-aldosterone system blockers after KDIGO stage 3 acute kidney injury: use and impact on 2-year mortality in the AKIKI trial. https://t.co/zvGhH3bCJr

29 May 2019

Reply Repost Favourite

Renin-angiotensin-aldosterone system blockers after KDIGO stage 3 acute kidney injury: use and impact on 2-year mortality in the AKIKI trial https://t.co/wQ5haML1SB #

12 May 2019

Reply Repost Favourite

RT @JonathanNefro: Administrar INHIBIDORES del SISTEMA RENINA ANGIOTENSINA ALDOSTERONA al alta de terapia intensiva en los que habían tenid…

08 May 2019

Reply Repost Favourite

RT @JonathanNefro: Administrar INHIBIDORES del SISTEMA RENINA ANGIOTENSINA ALDOSTERONA al alta de terapia intensiva en los que habían tenid…

06 May 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.